
Psychemedics Corporation PMD
Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Psychemedics Corporation Kurzfristige Verbindlichkeiten 2011-2026 | PMD
Kurzfristige Verbindlichkeiten Jährlich Psychemedics Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.71 M | 5.72 M | 5.83 M | 3.94 M | 5.84 M | 4.06 M | 4.22 M | 4.5 M | 3.56 M | 3.6 M | 2.96 M | 2.08 M | 2.28 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.84 M | 2.08 M | 4.1 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Biodesix
BDSX
|
14.3 M | $ 15.79 | 4.78 % | $ 2.05 B | ||
|
Agilent Technologies
A
|
1.71 B | $ 115.15 | -0.26 % | $ 35 B | ||
|
Biomerica
BMRA
|
1.74 M | $ 2.15 | -1.15 % | $ 4.94 M | ||
|
BioNano Genomics
BNGO
|
22.9 M | $ 1.16 | -3.75 % | $ 6.32 M | ||
|
Burning Rock Biotech Limited
BNR
|
372 M | $ 16.25 | 0.28 % | $ 175 M | ||
|
CareDx, Inc
CDNA
|
89.8 M | $ 18.22 | -0.49 % | $ 971 M | ||
|
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
3.54 M | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | ||
|
Charles River Laboratories International
CRL
|
1.12 B | $ 167.39 | -3.74 % | $ 8.3 B | ||
|
Castle Biosciences
CSTL
|
49.4 M | $ 25.23 | 1.57 % | $ 701 M | ||
|
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M | ||
|
Danaher Corporation
DHR
|
6.81 B | $ 192.1 | 0.51 % | $ 137 B | ||
|
DexCom
DXCM
|
2.14 B | $ 63.05 | 1.33 % | $ 24.6 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M | ||
|
Fulgent Genetics
FLGT
|
72.9 M | $ 16.55 | -1.61 % | $ 500 M | ||
|
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M | ||
|
Guardant Health
GH
|
303 M | $ 90.82 | -3.21 % | $ 11.4 B | ||
|
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | ||
|
ICON Public Limited Company
ICLR
|
2.8 B | $ 111.31 | -2.52 % | $ 9.18 B | ||
|
Interpace Biosciences
IDXG
|
5.1 M | $ 1.92 | -1.92 % | $ 8.49 M | ||
|
Illumina
ILMN
|
1.55 B | $ 127.58 | 0.15 % | $ 20.3 B | ||
|
IQVIA Holdings
IQV
|
8.34 B | $ 170.35 | -1.67 % | $ 29.3 B | ||
|
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | ||
|
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | ||
|
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 274.41 | 0.22 % | $ 22.8 B | ||
|
Lantheus Holdings
LNTH
|
333 M | $ 75.97 | -0.17 % | $ 5.13 B | ||
|
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | ||
|
Medpace Holdings
MEDP
|
1.34 B | $ 495.2 | -0.63 % | $ 14.3 B | ||
|
Mettler-Toledo International
MTD
|
1.2 B | $ 1 263.66 | 0.3 % | $ 26 B | ||
|
Myriad Genetics
MYGN
|
134 M | $ 4.79 | 0.74 % | $ 444 M | ||
|
ENDRA Life Sciences
NDRA
|
751 K | $ 4.56 | -2.72 % | $ 3.59 M | ||
|
NeoGenomics
NEO
|
88.3 M | $ 7.99 | -0.13 % | $ 1.02 B | ||
|
Neogen Corporation
NEOG
|
174 M | $ 9.49 | 0.8 % | $ 2.06 B | ||
|
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | ||
|
National Research Corporation
NRC
|
36.6 M | $ 17.52 | 2.07 % | $ 392 M | ||
|
Natera
NTRA
|
310 M | $ 205.75 | -1.07 % | $ 20.2 B | ||
|
Pacific Biosciences of California
PACB
|
72.8 M | $ 1.41 | 4.85 % | $ 423 M | ||
|
Precipio
PRPO
|
3.75 M | $ 26.16 | 2.35 % | $ 42 M | ||
|
Personalis
PSNL
|
31.1 M | $ 6.62 | 0.53 % | $ 392 M | ||
|
RadNet
RDNT
|
587 M | $ 55.4 | 1.11 % | $ 4.17 B | ||
|
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | ||
|
Senseonics Holdings
SENS
|
24.3 M | $ 6.93 | 0.36 % | $ 289 M |